Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP) Institutional Ownership

Q: What is CUSIP 890260847?

CUSIP 890260847 is the security identifier used in SEC filing datasets for TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share.

Q: Who owns TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

CUSIP: 890260847

13F Institutional Holders and Ownership History from Q2 2024 to Q2 2025

Type / Class: Equity / Common Stock, par value $0.001 per share
Symbol: TNXP on Nasdaq
Price per share: $0.15
Price from insider filings: $0.15

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Investment Quick Answers

What is CUSIP 890260847?
CUSIP 890260847 identifies TNXP - Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 890260847:

Q2 2025 (0 holders) Q1 2025 (1 holder) Q4 2024 (30 holders) Q3 2024 (5 holders) Q2 2024 (9 holders)

Institutional Holders of Tonix Pharmaceuticals Holding Corp. - Common Stock, par value $0.001 per share (TNXP) across Reporting Periods

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Price (Median)	Investors
2025 Q2	0	$0	-$1,521	$0.15	0
2025 Q1	10,000	$1,521	-$4,838,127	$0.15	1
2024 Q4	14,675,770	$4,839,651	+$962,491	$0.33	30
2024 Q3	70,592	$10,465	-$28,545	$1.00	5
2024 Q2	58,027	$39,187	+$39,187	$1.00	9